Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Dyspnea, Paroxysmal × Fentanyl × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 24 Neoplasms 20 Colonic Neoplasms 7 Cancer Pain 6 Agnosia 6 Breast Neoplasms 5 Breakthrough Pain 5 Rectal Neoplasms 4 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Pain, Postoperative 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Chronic Pain 3 Breakthrough Cancer Pain 3 Waldenstrom Macroglobulinemia 2 Uterine Cervical Neoplasms 2 Thrombocythemia, Essential 2 Sezary Syndrome 2 Primary Myelofibrosis 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Polycythemia Vera 2 Pleural Effusion, Malignant 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2

Interventions

Furosemide 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04635852 2020-11-19

EFFENDYS

University of Cologne

Phase 2 Completed

Dyspnea, Paroxysmal, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡